About Megan Heaps

Articles by Megan Heaps

ASH 2025 Updates: What’s New in Waldenström Macroglobulinemia Treatment
Jan 30, 2026
Fusing Non-Covalent and Covalent BTK Inhibitors for CLL with Rocbrutinib
Jan 26, 2026
Hodgkin Lymphoma Treatment and Testing Updates from ASH 2025
Jan 26, 2026
Lymph Node Biopsy for Lymphoma: What to Expect and How to Understand Your Results
Jan 23, 2026
Comparing Fixed-Duration vs Continuous Treatment for CLL
Jan 22, 2026
CAR T-cell Therapy and Fertility | Considerations for Patients
Jan 09, 2026
Pirtobrutinib vs Ibrutinib for CLL/SLL Patients Who Haven’t Had a BTK Inhibitor
Dec 31, 2025
MBL, CHIP, and Blood Cancer Risk: What New Research Says About These Blood Cancer Precursor Conditions
Dec 29, 2025
Latest Follicular Lymphoma Research from ASH 2025
Dec 18, 2025
U.S. FDA Approves Liso-cel (Breyanzi) for Marginal Zone Lymphoma
Dec 08, 2025
ASH 2025: New CAR T-Cell Therapies for Relapsed B-Cell Lymphoma
Dec 08, 2025
How Should CLL Treatments Be Sequenced?
Dec 01, 2025
Managing Family Dynamics During Cancer Care
Nov 21, 2025
U.S. FDA Approves Epcoritamab (Epkinly) Combination for Follicular Lymphoma
Nov 18, 2025
What Are BTK Inhibitors for Lymphoma?
Nov 13, 2025
Flow Cytometry Test: What Leukemia and Lymphoma Patients Should Know
Sep 24, 2025
What You Need to Know as a Newly Diagnosed Blood Cancer Patient and How to Advocate for Yourself
Sep 16, 2025
World Lymphoma Day: News You May Have Missed
Sep 15, 2025
Statins Shown to Improve Outcomes for People with CLL/SLL Taking Ibrutinib
Sep 12, 2025
Lymphedema After Radiation for Lymphoma: Signs, Risk Factors, and Treatment
Aug 22, 2025
Coping With Life After Lymphoma: Mind-Body Tips for Survivorship
Jul 31, 2025
Aromatherapy for Nausea: Four Essential Oils to Try
Jul 31, 2025
Understanding Secondary Cancer Risks in CLL: Signs, Screening, and Prevention
Jul 31, 2025
Real-World Data Shows Zanubrutinib (Brukinsa) Takes the Lead in Covalent BTK Inhibitors
Jul 25, 2025